Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Open in API
Filings indexed 918 across all filing types
Latest filing 2014-06-25 Regulatory Filings
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings
2014-06-25 English
FWP
Capital/Financing Update Classification · 100% confidence The document is an Issuer Free Writing Prospectus (FWP) filed pursuant to Rule 433 of the Securities Act of 1933. It relates to an initial public offering (IPO) of common stock by Amphastar Pharmaceuticals, Inc. The text includes detailed information about the offering, such as number of shares, pricing, use of proceeds, dilution, capitalization, and updates to a preliminary prospectus. This type of document is a prospectus supplement or offering update, which is part of capital raising activities. It is not a financial report, earnings release, or management discussion, but rather a disclosure related to financing and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2014-06-25 English
S-1MEF
Regulatory Filings Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, specifically a Rule 462(b) filing to increase the number of shares offered in a public offering. It is a registration statement related to securities offering, not a financial report, earnings release, or management discussion. The document is a regulatory filing related to capital raising but is not an earnings release or capital/financing update announcement per se. Given the nature of the document as a registration statement for securities offering, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and filings that do not fit other categories.
2014-06-25 English
Regulatory Filings 2014
Regulatory Filings
2014-06-25 English
3
Director's Dealing
2014-06-25 English
3
Director's Dealing
2014-06-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.